Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Most peptides studied show similar safety profiles in men and women
BPC-157 Read the full profile Site of action (Localized) Origin (Gastric juice fragment) Supports angiogenesis Typical research dose (200500 mcg/day) Typical frequency (12x daily) Typical cycle length (46 weeks) Subcutaneous injection WADA-banned since 2022 Studied alone (no pairing required) TB-500 Read the full profile Site of action (Systemic) Origin (Thymosin Beta-4 fragment) Supports angiogenesis Regulates actin / cell migration Typical research dose (25 mg/week) Typical frequency (23x weekly) Typical cycle length (48 weeks) Subcutaneous injection WADA-banned since 2022 Studied alone (no pairing required) Our top-rated vendor Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing no paid placements, no affiliate influence
BPC-157 shows stronger effect sizes in animal tendon models but that advantage cannot be extrapolated to humans without trials
The 19 peptides placed on Category 2 in 2023 cannot currently be legally compounded
A.PizzitelliM
Rexar Technical Compound Datasheet (PDF) Molecular structure data and selected physicochemical properties can be consulted via: Dihexa on PubChem Dihexa is a synthetic oligopeptide-derived compound incorporating amino acid residues and an aliphatic acyl chain within a multi-amide framework
US$ 26.91
US$ 22.75
US$ 24.03
US$ 21.97
